RNTX
Rein Therapeutics, Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$0.80
+1.37%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-13.5%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| May 28, 2026 | VON RICKENBACH JOSEF H · director | Purchase | 23,190 | $1.06 |
| May 28, 2026 | VON RICKENBACH JOSEF H · director | Purchase | 15,950 | $1.05 |
| May 28, 2026 | VON RICKENBACH JOSEF H · director | Purchase | 3,420 | $1.04 |
| May 28, 2026 | VON RICKENBACH JOSEF H · director | Purchase | 4,500 | $1.07 |
| May 13, 2026 | WINDSOR JAMES BRIAN · director, officer: See Remarks | Purchase | 25,000 | $1.00 |
| May 13, 2026 | WINDSOR JAMES BRIAN · director, officer: See Remarks | A-Award | 150,000 | $1.17 |
| Nov 18, 2025 | Voss Capital, LP · 10 percent owner | Purchase | 104,183 | $1.22 |
| Oct 28, 2025 | Voss Capital, LP · 10 percent owner | Purchase | 4,840 | $1.37 |
| Oct 28, 2025 | Voss Capital, LP · 10 percent owner | Purchase | 178,392 | $1.39 |
| Oct 28, 2025 | Voss Capital, LP · 10 percent owner | Purchase | 30,176 | $1.39 |
| Oct 28, 2025 | Voss Capital, LP · 10 percent owner | Purchase | 92,642 | $1.37 |
| Jul 23, 2025 | Musso Alan A · director | A-Award | 17,500 | $1.55 |
| Jul 23, 2025 | Aivado Manuel · director | A-Award | 17,500 | $1.55 |
| Jul 23, 2025 | Fairey William · director | A-Award | 17,500 | $1.55 |
| Jul 23, 2025 | Ambros Reinhard J. · director | A-Award | 17,500 | $1.55 |
| Jul 23, 2025 | VON RICKENBACH JOSEF H · director | A-Award | 17,500 | $1.55 |
Institutional positioning
13F filings over the trailing two quarters
New 32Increased 33Reduced 9Sold out 6
| Filer | Action | Shares | Filed |
|---|---|---|---|
| Voss Capital, LP | Increased | 5,261,921 | Aug 14, 2026 |
| Cable Car Capital, LP | Increased | 5,195,000 | Aug 14, 2026 |
| ADAR1 Capital Management, LLC | New Position | 4,500,000 | Aug 14, 2026 |
| VOSS CAPITAL, LLC | Increased | 4,388,362 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 3,377,910 | Aug 13, 2026 |
| BIOS Capital Management, LP | Increased | 2,982,375 | Aug 14, 2026 |
| Ikarian Capital, LLC | New Position | 2,950,000 | Aug 14, 2026 |
| GREAT POINT PARTNERS LLC | New Position | 2,575,000 | Aug 14, 2026 |
| CITADEL ADVISORS LLC | New Position | 2,438,711 | Sep 2, 2026 |
| BIOS CAPITAL MANAGEMENT, LP | Increased | 1,982,375 | May 13, 2026 |
| Velan Capital Investment Management LP | New Position | 1,700,000 | Aug 14, 2026 |
| Senvest Management, LLC | Increased | 1,230,895 | Aug 14, 2026 |
| Prosight Management, LP | Increased | 1,100,000 | Aug 14, 2026 |
| Bleichroeder LP | New Position | 1,000,000 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 998,521 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing May 28, 2026